Metronomic capecitabine versus doxorubicin in advanced hepatocellular carcinoma
Gehan Abd Elatti Khedr, Sherif Farouk Elzawawy, Ahmad Gaber Gowil, Amany Saleh Elyamany, Mohamed Eshafei
Korean J Clin Oncol. 2016;12(1):32-40.   Published online 2016 Jun 30     DOI: https://doi.org/10.14216/kjco.16006
Citations to this article as recorded by Crossref logo
What is the real value of metronomic chemotherapy in the treatment of gastrointestinal cancer?
Haidar El Darsa, Rola El Sayed, Omar Abdel-Rahman
Expert Opinion on Pharmacotherapy.2021; 22(17): 2297.     CrossRef
Rationale for the use of metronomic chemotherapy in gastrointestinal cancer
Roberto Filippi, Pasquale Lombardi, Ilaria Depetris, Elisabetta Fenocchio, Virginia QuarĂ , Giovanna ChilĂ , Massimo Aglietta, Francesco Leone
Expert Opinion on Pharmacotherapy.2018; 19(13): 1451.     CrossRef